Literature DB >> 32703717

Neck-sparing short femoral stems: A meta-analysis.

Sivan Sivaloganathan1, Cédric Maillot2, Ciara Harman3, Loic Villet4, Charles Rivière5.   

Abstract

BACKGROUND: Neck sparing short femoral stems are supposed to ease restoration of the proximal femoral anatomy and physiological hip biomechanics. This stem design is of particular interest as they have the potential to generate prosthetic hips that have higher functional performance with an improved lifespan, and revise more easily. Unlike previously published meta-analysis, this meta-analysis was initiated to determine if neck sparing short femoral stems compared to conventional stems: (1) resulted in improved functional performance; (2) reduced risk of thigh pain; (3) reduced risk of reoperation/revision, and 4) reduced stress shielding related bone loss in the proximal femur.
MATERIAL AND METHODS: Literature databases were searched between 1st January 2005 and 30th March 2019. The primary search was conducted using the electronic databases MEDLINE, EMBASE, PubMed, Open Grey, Trip Pro, Evidence Search, and Cochrane. Eligible studies were assessed for homogeneity, with continuous outcomes expressed as standardized mean difference with 95% confidence interval and dichotomous data as odds-ratio with 95% confidence interval.
RESULTS: Ten randomised clinical trials were eligible; these trials included 1259 total hip arthroplasty procedures, inclusive of 616 neck sparing short stems and 643 conventional stems. We were not able to find a significant functional advantage of using neck sparing short stems based on Harris Hip scores (0.0850; 95% CI: -0.03 to 0.20 [p=0.40]) and WOMAC scores (-0.0605; 95% CI: -0.03 to 0.15 [p=0.87]). We found a trend in favour of neck sparing short stems to reduce the risk of thigh pain but this was non significant (odds ratio of 0.11; 95% CI: 0.03 to 0.43 [p=0.178]). Neck sparing short stems were associated with similar early- to mid-term dislocation and revision rates compared to conventional stems with odds ratio of 1.435 (95% CI: 0.545 to 3.780 [p=0.968]) and of 0.581 (95% CI: 0.220 to 1.532 [p=0.972]), respectively. Neck sparing short stems were found to have less bone loss in both Gruen zones 1 and 7 (3.324; 95% CI: -7.683 to 1.036 [p<0.001], and of -4.632; 95% CI: -9682 to 0.418 [p<0.001], respectively). DISCUSSION/
CONCLUSION: Neck sparing short femoral stems achieve excellent early to mid-term outcomes in both clinical and radiological outcome scores that are in keeping with conventional stems functionally. Hitherto, results from this meta-analysis suggest that neck-sparing stems may achieve better maintenance of bone mineral density than their conventional counterparts, in addition to fewer cases of thigh pain. LEVEL OF EVIDENCE: I; meta-analysis.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anatomic alignment; Femoral component; Hip replacement; Kinematic alignment; Neck sparing; Short stem

Mesh:

Year:  2020        PMID: 32703717     DOI: 10.1016/j.otsr.2020.05.004

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  3 in total

1.  MINIMA Short Stem Versus Standard Profemur (TL) Stem in Primary Total Hip Replacement: A Comparative Study.

Authors:  Stylianos Tottas; Athanasios Ververidis; Ioannis Kougioumtzis; Konstantinos Tilkeridis; Christina Tsigalou; Makrina Karaglani; Georgios Drosos
Journal:  Cureus       Date:  2022-04-02

2.  Primary outcomes of a femoral neck-preserving stem: a multicentre clinical-radiological analysis at 5-year follow-up.

Authors:  Daniel Godoy-Monzon; Saul Martinez; Javier Perez Torres; Felix Eduardo Avendano Duran; Jose Manuel Pascual; Agustin Maria Garcia-Mansilla
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-05-26

3.  Biomechanics of a cemented short stem: a comparative in vitro study regarding primary stability and maximum fracture load.

Authors:  Tobias Freitag; Karl Philipp Kutzner; Ralf Bieger; Heiko Reichel; Anita Ignatius; Lutz Dürselen
Journal:  Arch Orthop Trauma Surg       Date:  2021-03-23       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.